Russia posts increase in sales of domestic drugs this year

The share of domestic drugs in the overall sales structure in the Russian pharmaceutical market reached 58% this year, which is a historical record for Russia in the last 30 years, according to recent statistics published by the Russian Ministry of Health and some local analytical agencies in the field of pharmaceutics, reports The Pharma Letter’s local correspondent.

According to the sources, for comparison, in 2017 the share of domestic drugs was only 40%.

One of the reasons of this is due to the price of the locally-made drugs, which on average are 2.5 times cheaper than their imported analogues, being currently estimated at 119 roubles ($2) per package. Still, in terms of value, the share of domestic drugs remains at a generally low level, not exceeding 30%.